Difference between revisions of "TDP-43"

From Libre Pathology
Jump to navigation Jump to search
(+alzheimer)
(+cte)
Line 26: Line 26:
*[[FTLD TDP-43]]
*[[FTLD TDP-43]]
* Alzheimer disease.<ref>{{Cite journal  | last1 = Wilson | first1 = AC. | last2 = Dugger | first2 = BN. | last3 = Dickson | first3 = DW. | last4 = Wang | first4 = DS. | title = TDP-43 in aging and Alzheimer's disease - a review. | journal = Int J Clin Exp Pathol | volume = 4 | issue = 2 | pages = 147-55 | month = Jan | year = 2011 | doi =  | PMID = 21326809 }}</ref>
* Alzheimer disease.<ref>{{Cite journal  | last1 = Wilson | first1 = AC. | last2 = Dugger | first2 = BN. | last3 = Dickson | first3 = DW. | last4 = Wang | first4 = DS. | title = TDP-43 in aging and Alzheimer's disease - a review. | journal = Int J Clin Exp Pathol | volume = 4 | issue = 2 | pages = 147-55 | month = Jan | year = 2011 | doi =  | PMID = 21326809 }}</ref>
*[[Chronic traumatic encephalopathy]] (CTE).<ref>{{Cite journal  | last1 = McKee | first1 = AC. | last2 = Cairns | first2 = NJ. | last3 = Dickson | first3 = DW. | last4 = Folkerth | first4 = RD. | last5 = Keene | first5 = CD. | last6 = Litvan | first6 = I. | last7 = Perl | first7 = DP. | last8 = Stein | first8 = TD. | last9 = Vonsattel | first9 = JP. | title = The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. | journal = Acta Neuropathol | volume = 131 | issue = 1 | pages = 75-86 | month = Jan | year = 2016 | doi = 10.1007/s00401-015-1515-z | PMID = 26667418 }}</ref>
*In 30% of non-demented individuals 65yrs and older.<ref>{{Cite journal  | last1 = Wilson | first1 = AC. | last2 = Dugger | first2 = BN. | last3 = Dickson | first3 = DW. | last4 = Wang | first4 = DS. | title = TDP-43 in aging and Alzheimer's disease - a review. | journal = Int J Clin Exp Pathol | volume = 4 | issue = 2 | pages = 147-55 | month = Jan | year = 2011 | doi =  | PMID = 21326809 }}</ref>





Revision as of 11:54, 5 July 2018

TDP-43
Immunostain in short

TDP-43 staining in FTLD-TDP43. (WC)
Normal staining pattern nuclear staining (physiological)
Positive cytoplasmatic staining (pathological)

TAR-DNA-binding Protein 43, abbreviated TDP-43 is a neuropathology immunostain used in neurodegenerative diseases.

  • Nuclear staining.

Inclusion morphology

  • fine / coarse skeins.
  • dot-like.
  • dense-round inclusions.

Inclusions found


Images

See also

References

  1. Wilson, AC.; Dugger, BN.; Dickson, DW.; Wang, DS. (Jan 2011). "TDP-43 in aging and Alzheimer's disease - a review.". Int J Clin Exp Pathol 4 (2): 147-55. PMID 21326809.
  2. McKee, AC.; Cairns, NJ.; Dickson, DW.; Folkerth, RD.; Keene, CD.; Litvan, I.; Perl, DP.; Stein, TD. et al. (Jan 2016). "The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy.". Acta Neuropathol 131 (1): 75-86. doi:10.1007/s00401-015-1515-z. PMID 26667418.
  3. Wilson, AC.; Dugger, BN.; Dickson, DW.; Wang, DS. (Jan 2011). "TDP-43 in aging and Alzheimer's disease - a review.". Int J Clin Exp Pathol 4 (2): 147-55. PMID 21326809.